治疗癌症疼痛的静脉胺:一个单一中心的回顾性分析,比较固定速率与基于体重的剂量
Leslie Siegel1, Kyle Quirk1, Gary Houchard1
1Department of Pharmacy, The Ohio State University James Comprehensive Cancer Center, Columbus, Ohio, USA.
Journal of pain & palliative care pharmacotherapy
|July 11, 2024
概括
固定速率静脉注射胺可能与基于体重的剂量对癌症疼痛一样有效. 这项研究发现,两种用于癌症疼痛管理的剂量策略之间的成功率没有显著差异.
科学领域:
- 疼痛管理 疼痛管理
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 低麻醉基他胺在治疗癌症疼痛方面表现有前途,但缺乏标准化剂量.
- 在癌症疼痛中静脉注射胺的最佳剂量策略尚不清楚.
研究的目的:
- 为了比较固定率与基于体重的胺胺剂量治疗癌症疼痛的成功率.
- 为了确定与成功的胺治疗相关的患者特征.
主要方法:
- 对105名非危急病情的成人癌症患者的回顾性审查,他们至少接受了24小时的胺.
- 成功被定义为疼痛评分,阿片类药物使用或每日阿片类药物剂量减少30%.
- 基于体重的剂量是以后计算的.
主要成果:
- 48.6%的患者对胺治疗有反应.
- 固定剂量和基于体重的胺剂量之间成功率没有显著差异.
- 受访者每日阿片类药物需求基线较高.
结论:
- 基于体重的胺剂量可能不会比癌症疼痛的固定剂量剂量提供额外的好处.
- 需要进一步的研究,以建立在瘤学中最佳的胺胺剂量协议.
相关概念视频
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
454
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
454
One-Compartment Model: IV Infusion
187
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
187
Parenteral Anesthetics: Overview
117
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
117
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158


